Capital World Investors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Capital World Investors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2021$42,655,000
+14.8%
1,457,280
-0.0%
0.01%
+16.7%
Q3 2021$37,147,000
-27.2%
1,457,892
+0.1%
0.01%
-33.3%
Q2 2021$51,028,000
-14.0%
1,457,110
+0.0%
0.01%
-18.2%
Q1 2021$59,348,000
-5.8%
1,456,390
+0.1%
0.01%
-8.3%
Q4 2020$62,999,000
-21.4%
1,454,609
+0.1%
0.01%
-33.3%
Q3 2020$80,142,000
-12.6%
1,453,421
+0.1%
0.02%
-18.2%
Q2 2020$91,702,000
+23.6%
1,452,595
+0.0%
0.02%0.0%
Q1 2020$74,206,000
+99.7%
1,452,448
+210.7%
0.02%
+175.0%
Q4 2019$37,163,000
+101.6%
467,520
+23.0%
0.01%
+100.0%
Q3 2019$18,438,000
+119.1%
380,000
+137.5%
0.00%
+100.0%
Q2 2019$8,416,000
-0.6%
160,0000.0%0.00%0.0%
Q1 2019$8,469,000
+28.9%
160,0000.0%0.00%0.0%
Q4 2018$6,568,000
+8.0%
160,0000.0%0.00%
+100.0%
Q3 2018$6,080,000
-15.9%
160,0000.0%0.00%
-50.0%
Q2 2018$7,232,000
-6.4%
160,0000.0%0.00%0.0%
Q1 2018$7,728,000160,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 327,905$17,248,0009.44%
Asymmetry Capital Management, L.P. 314,217$16,528,0008.95%
Perceptive Advisors 5,775,726$303,803,0006.97%
NEXTHERA CAPITAL LP 142,305$7,485,0006.23%
Grace Capital 244,914$12,882,0006.14%
Broadfin Capital, LLC 316,619$16,654,0003.62%
Ghost Tree Capital, LLC 300,000$15,780,0003.27%
ArchPoint Investors 156,635$8,239,0002.61%
STANSBERRY ASSET MANAGEMENT, LLC 114,562$6,026,0002.37%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 13,928$733,0002.07%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders